Heterodimers of glutamic acid
JW Babich, CN Zimmerman… - US Patent App. 11 …, 2008 - Google Patents
Publication Classification eroaryl or a CC substituted or unsubstituted alkyl, when (51) Int.
Cl. substituted, aryl, heteroaryland alkyl are substituted with A6K 49/00(2006.01) halogen …
Cl. substituted, aryl, heteroaryland alkyl are substituted with A6K 49/00(2006.01) halogen …
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
AP Kozikowski, JT Wroblewski, F Nan - US Patent 8,609,721, 2013 - Google Patents
Field of Classification Search(57) USPC............ 514/75, 574, 533, 616; 562/8, 10, 24: The
present invention relates to novel compounds and formu 560/38, 85; 564/15 lations thereof …
present invention relates to novel compounds and formu 560/38, 85; 564/15 lations thereof …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,046,054, 2018 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, V Chelvam, Y Kim, SA Kularatne - US Patent 9,951,324, 2018 - Google Patents
4, 691, 024 A 9/1987 Kunikatsu et al. 4, 713, 249 A 12/1987 Schroder 5, 103, 018 A 4/1992
Motomichi et al. 5, 266, 333 A 11/1993 Cady et al. 5, 418, 982 A 5/1995 Kishi 5, 627, 165 A …
Motomichi et al. 5, 266, 333 A 11/1993 Cady et al. 5, 418, 982 A 5/1995 Kishi 5, 627, 165 A …
Heterodimers of glutamic acid
JW Babich, CN Zimmerman, KP Maresca - US Patent 8,487,129, 2013 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
39365345&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
39365345&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,624,970, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
Conjugates for treating diseases caused by PSMA expressing cells
A6 IK 38/08(2006.01) C07K 5/10(2006.01)(57) ABSTRACT C07K 5/02(2006.01) C07K
5/II(2006.01) The invention described herein pertains to the diagnosis, C07K …
5/II(2006.01) The invention described herein pertains to the diagnosis, C07K …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,517,956, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,624,971, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,646,581, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …